Sandoz CEO Saynor Signals No Change To Focus Amid Strategic Review

Novartis Unit’s Strategy Remains Unaltered As Parent Company Explores All Options

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.